| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net loss from operations | ||||||
-45,147 | -55,765 | -36,028 | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||
Amortization of debt discount and debt issuance costs | ||||||
- | - | 6,079 | ||||
Change in fair value of warrants and embedded derivative | ||||||
- | 1,870 | -513 | ||||
Non-cash interest expense on convertible bridge notes | ||||||
- | - | 1,045 | ||||
Stock-based compensation | ||||||
3,895 | 7,599 | 462 | ||||
Depreciation and amortization | ||||||
249 | 66 | 32 | ||||
Net loss on settlement of convertible bridge note | ||||||
- | - | -3,868 | ||||
Amortization of marketable securities discount | ||||||
530 | 497 | - | ||||
Cloud computing arrangement implementation costs | ||||||
-1,114 | -107 | - | ||||
Noncash lease expense, net | ||||||
57 | - | - | ||||
Noncash portion of litigation settlement | ||||||
-16 | - | - | ||||
Other | ||||||
-76 | -12 | -436 | ||||
Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | ||||||
228 | 164 | 78 | ||||
Inventories | ||||||
4,961 | 1,621 | 279 | ||||
Prepaid expenses and other current assets | ||||||
-859 | 1,347 | 517 | ||||
Accounts payable | ||||||
2,797 | 1,858 | - | ||||
Accrued expense and other current liabilities | ||||||
-1,036 | 1,047 | - | ||||
Accounts payable and accrued expenses | ||||||
- | - | 212 | ||||
Deferred rent | ||||||
- | 61 | 48 | ||||
Net cash used in operating activities | ||||||
-45,066 | -47,110 | -25,329 | ||||
Cash flows from investing activities: | ||||||
Purchase of marketable securities | ||||||
37,224 | 81,058 | 32,427 | ||||
Proceeds from maturities of marketable securities | ||||||
88,266 | 44,509 | 8,460 | ||||
Purchases of property and equipment | ||||||
69 | 278 | 152 | ||||
Net cash provided by investing activities | ||||||
50,971 | -36,827 | -24,120 | ||||
Cash flows from financing activities: | ||||||
Proceeds from note issued | ||||||
807 | - | - | ||||
Repayments of note payable | ||||||
695 | - | - | ||||
Sale of common stock, net of related expenses | ||||||
- | 78,334 | - | ||||
Proceeds from shares issued in connection with employee stock purchase plan | ||||||
48 | - | - | ||||
Proceeds from issuance of Series B Preferred Units | ||||||
- | - | 46,911 | ||||
Financing costs related to the issuance of Series B Preferred Units | ||||||
- | - | 2,819 | ||||
Proceeds from issuance of convertible bridge notes | ||||||
- | - | 19,965 | ||||
Deferred financing fees | ||||||
- | - | 397 | ||||
Financing costs related to issuance of convertible bridge notes | ||||||
- | - | 1,170 | ||||
Net cash used in financing activities | ||||||
160 | 78,334 | 62,488 | ||||
Effect of changes in exchange rates on cash and cash equivalents | ||||||
-102 | -20 | - | ||||
Net increase/(decrease) in cash and cash equivalents | ||||||
5,963 | -5,623 | - | ||||
Effect of changes in exchange rates on cash and cash equivalents | ||||||
- | - | -231 | ||||
Net increase in cash and cash equivalents | ||||||
- | - | 12,807 | ||||
Supplemental schedule of noncash activity: | ||||||
Reclass of warrant liability to additional paid in capital | ||||||
- | 4,110 | - | ||||
Reclass of deferred financing costs to additional paid in capital | ||||||
- | 856 | - | ||||
Stock dividend distribution in connection with IPO | ||||||
- | 3,629 | - | ||||
Deferred financing costs included in accounts payable and accrued expenses | ||||||
- | - | 234 | ||||
Capitalized cloud computing arrangement costs included in accounts payable and accrued expenses | ||||||
- | 287 | - | ||||
Common units issued | ||||||
- | - | 5,194 | ||||
Conversion of convertible bridge notes, including accrued interest, to Series B Preferred Units | ||||||
- | - | 26,718 | ||||
Series B warrants issued in connection with convertible bridge notes | ||||||
- | - | 2,620 | ||||
Deferred financing costs accrued | ||||||
- | - | 458 | ||||
Cash paid during the year for: | ||||||
Income taxes paid | ||||||
29 | 45 | - | ||||
Interest paid | ||||||
3 | - | 0 | ||||
Series A Preferred Units | ||||||
Equity converted to common stock | ||||||
- | 53,518 | - | ||||
Series B Preferred Units | ||||||
Equity converted to common stock | ||||||
- | 68,755 | - | ||||
Common Units | ||||||
Equity converted to common stock | ||||||
- | 40,180 | - | ||||
Elimination of Liquidation Preference | ||||||
Common units issued | ||||||
- | - | 16,430 | ||||
Conversion of Series B Preferred Units | ||||||
Common units issued | ||||||
- | - | 4,074 | ||||
Common warrants issued in connection with Series B financing | ||||||
- | - | 362 | ||||